{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnsweringBody.=Department+of+Health&max-answer.dateOfAnswer=2015-01-13", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?AnsweringBody.=Department+of+Health&max-answer.dateOfAnswer=2015-01-13", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnsweringBody.=Department+of+Health&_metadata=all&max-answer.dateOfAnswer=2015-01-13", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&AnsweringBody.=Department+of+Health&max-answer.dateOfAnswer=2015-01-13", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnsweringBody.=Department+of+Health&max-answer.dateOfAnswer=2015-01-13", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?AnsweringBody.=Department+of+Health&max-answer.dateOfAnswer=2015-01-13", "items" : [{"_about" : "http://data.parliament.uk/resources/172790", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172790/answer", "answerText" : {"_value" : "

The Human Fertilisation and Embryology Authority (HFEA) has advised that in its 2014 report the Expert Panel, convened by the HFEA, concluded that, in relation to mosaicism in human morulae:<\/p>

<\/p>

<\/p>

<\/p>

\u201cAlthough experiments are already reported on ES cells and their derivatives with MST, further corroborative experiments would be valuable to demonstrate the degree of heteroplasmic mosaicism in morulae, and to provide data to address whether there was any amplification of mtDNA carried over.\u201d<\/p>

<\/p>

<\/p>

<\/p>

The Panel\u2019s report can be found on the HFEA\u2019s website at:<\/p>

<\/p>

<\/p>

<\/p>

http://www.hfea.gov.uk/6896.html<\/p>

<\/p>

<\/p>

<\/p>

The \u201calready reported\u201d experiments were published in Nature in 2013.<\/p>

<\/p>

<\/p>

<\/p>

At the time of writing the 2014 report, to the Panel\u2019s knowledge, this work had not been published in a peer-reviewed journal. The Department does not routinely publish scientific research conducted independently by others.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:21:10.37Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether the studies recommended by the Human Fertilisation and Embryology Authority's expert review panel in the publication, Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception: update, published in March 2013 on mosaicism in human morulae have been concluded; and in which peer-reviewed journal his Department plans to publish the findings of those studies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220195"} , {"_about" : "http://data.parliament.uk/resources/172792", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172792/answer", "answerText" : {"_value" : "

Information on the median waiting times for Improving Access to Psychological Therapies (IAPT) services by Clinical Commissioning Groups (CCGs) in Birmingham for 2013-14 is shown in the following table.<\/p>

<\/p>

<\/p>

<\/p>

<\/p><\/td>

Number of referrals entering treatment<\/p><\/td>

Median waiting time (days)<\/p><\/td><\/tr>

NHS Birmingham and South Central CCG<\/p><\/td>

3,320<\/p><\/td>

26<\/p><\/td><\/tr>

NHS Sandwell and West Birmingham CCG<\/p><\/td>

5,135<\/p><\/td>

25<\/p><\/td><\/tr>

NHS Birmingham Cross City CCG<\/p><\/td>

9,020<\/p><\/td>

29<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

Source: <\/em>Health and Social Care Information Centre (HSCIC), IAPT Dataset<\/p>

<\/p>

<\/p>

<\/p>

Notes:<\/em><\/p>

<\/p>

  1. It is not possible to separate Sandwell from NHS Sandwell and West Birmingham CCG; as such, data for Sandwell is also included in this response<\/li>
  2. The IAPT dataset contains information on referrals to IAPT services which provide talking therapies.<\/li>
  3. Waiting time is measured by counting the number of days between a referral being received and the first treatment appointment. Currently, the presence of a valid therapy type is used as an indicator of whether treatment was provided in the course of the appointment.<\/li>
  4. This data is based upon a count of referrals received by IAPT services, not distinct people. In order to be included in these figures, a referral must have had a first treatment appointment in the reporting period (1 April 2013 to 31 March 2014)<\/li><\/ol>

    <\/p>

    <\/strong><\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "answeringMemberConstituency" : {"_value" : "North Norfolk"} , "answeringMemberPrinted" : {"_value" : "Norman Lamb"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:33:09.74Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Health Services: Birmingham"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what the average waiting time is for talking therapy in Birmingham.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3913", "label" : {"_value" : "Biography information for Jack Dromey"} } , "tablingMemberConstituency" : {"_value" : "Birmingham, Erdington"} , "tablingMemberPrinted" : [{"_value" : "Jack Dromey"} ], "uin" : "220193"} , {"_about" : "http://data.parliament.uk/resources/172797", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172797/answer", "answerText" : {"_value" : "

    There are already arrangements in place to support children born with conditions relating.<\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:16:23.13Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether he plans to put contingency arrangements in place to ensure support for recipients of mitochondrial donation techniques in the event of failure or abnormal development in the resulting child.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"} } , "tablingMemberConstituency" : {"_value" : "North Tyneside"} , "tablingMemberPrinted" : [{"_value" : "Mrs Mary Glindon"} ], "uin" : "220183"} , {"_about" : "http://data.parliament.uk/resources/172798", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172798/answer", "answerText" : {"_value" : "

    Neither the nuclear DNA or mitochondrial DNA of the patient\u2019s egg is altered during the creation of an embryo during mitochondrial donation treatment, using the maternal spindle transfer (MST) and pro-nuclear transfer (PNT) techniques.<\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:21:06.287Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment his Department has made of whether eggs used in the creation of embryos through maternal spindle transfer or pronuclear transfer have had their mitochondrial or nuclear genes altered in the process.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"} } , "tablingMemberConstituency" : {"_value" : "North Tyneside"} , "tablingMemberPrinted" : [{"_value" : "Mrs Mary Glindon"} ], "uin" : "220181"} , {"_about" : "http://data.parliament.uk/resources/172799", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172799/answer", "answerText" : {"_value" : "

    I refer the hon. Member to the answer given to the hon. Member for Congleton (Fiona Bruce) on 3 December 2014 to Question 216104<\/a>.<\/p>

    <\/p>

    <\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T16:17:02.577Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the implications for public safety in relation to his policy on mitochondrial transfer of the study by Professor John Zhang et al, published in Fertility and Sterility, Vol 80, Suppl. 3, September 2003.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4126", "label" : {"_value" : "Biography information for Mary Glindon"} } , "tablingMemberConstituency" : {"_value" : "North Tyneside"} , "tablingMemberPrinted" : [{"_value" : "Mrs Mary Glindon"} ], "uin" : "220182"} , {"_about" : "http://data.parliament.uk/resources/172800", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172800/answer", "answerText" : {"_value" : "

    The information requested is presented in the table below. For the Department\u2019s executive non-departmental public bodies the information requested is not held centrally: consequently this data has been provided by the individual bodies.<\/p>

    <\/p>

    <\/p>

    <\/p>

    <\/p>

    Name of organisation<\/p>

    <\/p><\/td>

    Number of staff absent from work through sickness during December 2014<\/p><\/td><\/tr>

    Department of Health<\/p><\/td>

    195<\/p><\/td><\/tr>

    NHS England<\/p><\/td>

    729<\/p><\/td><\/tr>

    Monitor<\/p><\/td>

    36<\/p><\/td><\/tr>

    Care Quality Commission<\/p><\/td>

    206<\/p><\/td><\/tr>

    National Institute for Health and Care Excellence<\/p><\/td>

    111<\/p><\/td><\/tr>

    Health and Social Care Information Centre<\/p><\/td>

    256<\/p><\/td><\/tr>

    Human Fertilisation and Embryology Authority<\/p><\/td>

    5<\/p><\/td><\/tr>

    Health Research Authority<\/p><\/td>

    23<\/p><\/td><\/tr>

    Human Tissue Authority<\/p><\/td>

    4<\/p><\/td><\/tr><\/tbody><\/table>

    <\/p>

    <\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3932", "label" : {"_value" : "Biography information for Dr Dan Poulter"} } , "answeringMemberConstituency" : {"_value" : "Central Suffolk and North Ipswich"} , "answeringMemberPrinted" : {"_value" : "Dr Daniel Poulter"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:39:02.53Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Sick Leave"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, how many staff in (a) his Department and (b) each of its non-departmental public bodies were absent from work through sickness in December 2014.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4036", "label" : {"_value" : "Biography information for Luciana Berger"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Luciana Berger"} ], "uin" : "220225"} , {"_about" : "http://data.parliament.uk/resources/172801", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172801/answer", "answerText" : {"_value" : "

    The Health and Safety Executive (HSE) has run a number of asbestos related awareness raising campaigns including the \u2018Hidden Killer\u2019 campaign in 2008-09; the asbestos \u2018Training Pledge\u2019 in 2010; and the current \u2018Beware Asbestos\u2019 campaign.<\/p>

    <\/p>

    <\/p>

    <\/p>

    The \u2018Beware Asbestos\u2019 campaign was launched in October 2014 and is aimed at trades in which people who may disturb asbestos-containing materials in their day to day work. It includes information on identifying asbestos-containing materials and simple, easy to understand advice on how to avoid exposure to asbestos when carrying out a range of common work activities on such materials. It features a smartphone \u2018app\u2019 as a means of delivering this information to.<\/p>

    <\/p>

    <\/p>

    <\/p>

    HSE has guidance on the health risks from asbestos, including mesothelioma on its dedicated asbestos related web pages, together with comprehensive information on how to comply with the legal controls covering work with asbestos. This is available at<\/p>

    <\/p>

    <\/p>

    <\/p>

    www.hse.gov.uk/asbestos<\/a><\/p>

    <\/p>

    <\/strong><\/p>

    <\/p>

    Information about causes and symptoms of mesothelioma and advice on seeking help is also available on NHS Choices at<\/p>

    <\/p>

    <\/p>

    www.nhs.uk/Livewell/Lungcancer/Pages/Asbestosandlungcancer.aspx<\/a><\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:08:07.217Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mesothelioma"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what steps the Government is taking to raise awareness of mesothelioma and its cause by (a) exposure to asbestos and (b) other causes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3931", "label" : {"_value" : "Biography information for Dr Julian Huppert"} } , "tablingMemberConstituency" : {"_value" : "Cambridge"} , "tablingMemberPrinted" : [{"_value" : "Dr Julian Huppert"} ], "uin" : "220226"} , {"_about" : "http://data.parliament.uk/resources/172802", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172802/answer", "answerText" : {"_value" : "

    The Human Fertilisation and Embryology Authority (HFEA) has advised that some relevant experiments have been carried out in the macaque a summary of which can be found at paragraph 2.3.4 of the 2013 report of the Expert Panel convened by the HFEA. The report can be found on the HFEA\u2019s website at:<\/p>

    <\/p>

    <\/p>

    <\/p>

    http://www.hfea.gov.uk/6896.html<\/p>

    <\/p>

    <\/p>

    <\/p>

    The results were published in Cell Reports in 2012.<\/p>

    <\/p>

    <\/p>

    <\/p>

    The use of non-human primate experiments was deemed by the Panel, in its 2013 and 2014 reports, to no longer be necessary.<\/p>

    <\/p>

    <\/p>

    <\/p>

    The Department does not routinely publish scientific research conducted independently by others.<\/p>

    <\/p>

    <\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:09:38.837Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether the experiment on mitochondrial DNA carry-over on non-human primate model into the possible heteroplasmy of tissues in the foetus, recommended by the Human Fertilisation and Embryology Authority's expert panel in its publication Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception, published April 2011, has been concluded; and in which peer-reviewed journal he plans to publish the results of that experiment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220220"} , {"_about" : "http://data.parliament.uk/resources/172805", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172805/answer", "answerText" : {"_value" : "

    The Human Fertilisation and Embryology Authority (HFEA) has advised that at the time of writing its 2014 report that to, the Expert Panel\u2019s knowledge, convened by the HFEA, relevant results relating to these further had not been being published in a peer-reviewed journal.<\/p>

    <\/p>

    <\/p>

    <\/p>

    However, the Panel recognised that advances in cryopreservation are being made generally within the context of assisted reproduction technology.<\/p>

    <\/p>

    <\/p>

    <\/p>

    The Department does not routinely publish scientific research conducted independently by others.<\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T16:16:42.033Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether the experiment on vitrifying zygotes created through pronuclear transfer, recommended by the Human Fertilisation and Embryology Authority's expert panel in its publication Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception, published in April 2011, has been concluded; and in which open access peer-reviewed journal he plans to publish the results of that experiment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220217"} , {"_about" : "http://data.parliament.uk/resources/172806", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/172806/answer", "answerText" : {"_value" : "

    The Human Fertilisation and Embryology Authority (HFEA) has advised that the Expert Panel it convened revised this recommended research to the following, as outlined in its 2013 and 2014 reports:<\/p>

    <\/p>

    <\/p>

    <\/p>

    \u201cTests for heteroplasmy should be carried out on primordial germ cells obtained from human ES cells derived from blastocysts created through MST and PNT where the oocytes had variant or abnormal mtDNA. If primordial germ cell derivation is not possible or limitations in the model undermine its utility, clonal analysis of single cell-derived human ES cells could be used. Comparisons beginning with blastocysts known to be heteroplasmic for variant or abnormal mtDNA would be informative. This recommendation still stands.\u201d<\/p>

    <\/p>

    <\/p>

    <\/p>

    The Panel\u2019s reports can be found on the HFEA\u2019s website at:<\/p>

    <\/p>

    <\/p>

    <\/p>

    http://www.hfea.gov.uk/6896.html<\/a><\/p>

    <\/p>

    <\/p>

    <\/p>

    The Panel\u2019s rationale regarding experiments using abnormal mitochondria is outlined at section 3.5 of their 2014 report.<\/p>

    <\/p>

    <\/p>

    <\/p>

    At the time of writing the 2014 report, to the Panel\u2019s knowledge, this work had not been published in a peer-reviewed journal.<\/p>

    <\/p>

    <\/p>

    <\/p>

    The Department does not routinely publish scientific research conducted independently by others.<\/p>

    <\/p>

    <\/p>

    <\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"} } , "answeringMemberConstituency" : {"_value" : "Battersea"} , "answeringMemberPrinted" : {"_value" : "Jane Ellison"} , "dateOfAnswer" : {"_value" : "2015-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-01-13T15:35:26.497Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-01-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "IVF"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, whether the experiments on human embryonic stem cells derived from blastocysts that are heteroplasmic for abnormal mitochondrial DNA (mtDNA) and blastocysts created through maternal spindle transfer and pronuclear transfer where the oocytes had abnormal mtDNA, recommended by the Human Fertilisation and Embryology Authority's expert panel in its publication Scientific review of the safety and efficacy of methods to avoid mitochondrial disease through assisted conception, published April 2011, has been concluded; and in which peer-reviewed journal he plans to publish the results of those experiments.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3958", "label" : {"_value" : "Biography information for Fiona Bruce"} } , "tablingMemberConstituency" : {"_value" : "Congleton"} , "tablingMemberPrinted" : [{"_value" : "Fiona Bruce"} ], "uin" : "220218"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&AnsweringBody.=Department+of+Health&max-answer.dateOfAnswer=2015-01-13", "page" : 0, "startIndex" : 1, "totalResults" : 4252, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }